Stock Taper 
OPALEYE MANAGEMENT INC.
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Ocular Therapeutix, Inc. | OCUL | 600K | $5.89M |
 Stoke Therapeutics, Inc. | STOK | 700K | $22.9M |
 Monte Rosa Therapeutics, Inc. | GLUE | 745K | $18.03M |
 Disc Medicine, Inc. | IRON | 855K | $62.53M |
 Relmada Therapeutics, Inc. | RLMD | 935K | $6.47M |
 Rocket Pharmaceuticals, Inc. | RCKT | 1M | $3.42M |
 Replimune Group, Inc. | REPL | 1.38M | $15.33M |
 Verastem, Inc. | VSTM | 1.8M | $6.88M |
 Harrow Health, Inc. | HROW | 2.4M | $101.93M |
 Liquidia Corporation | LQDA | 2.45M | $195.14M |
 Eton Pharmaceuticals, Inc. | ETON | 2.86M | $103.53M |
 MeiraGTx Holdings plc | MGTX | 3.55M | $47.96M |
 Editas Medicine, Inc. | EDIT | 3.86M | $12.51M |